ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/08/19 | 2,184 | 2,203 | 2,181 | 2,189 | -11 | -0.5% | 28,400 |
2024/08/16 | 2,196 | 2,200 | 2,174 | 2,200 | +31 | +1.4% | 47,700 |
2024/08/15 | 2,170 | 2,170 | 2,136 | 2,169 | +11 | +0.5% | 29,700 |
2024/08/14 | 2,130 | 2,165 | 2,130 | 2,158 | +28 | +1.3% | 33,000 |
2024/08/13 | 2,095 | 2,130 | 2,076 | 2,130 | +38 | +1.8% | 38,600 |
2024/08/09 | 2,128 | 2,128 | 2,061 | 2,092 | +8 | +0.4% | 76,400 |
2024/08/08 | 2,050 | 2,127 | 2,020 | 2,084 | -11 | -0.5% | 54,000 |
2024/08/07 | 2,090 | 2,166 | 2,067 | 2,095 | +12 | +0.6% | 73,800 |
2024/08/06 | 2,059 | 2,115 | 2,042 | 2,083 | +74 | +3.7% | 100,200 |
2024/08/05 | 1,989 | 2,108 | 1,970 | 2,009 | -106 | -5% | 118,300 |
2024/08/02 | 2,234 | 2,240 | 2,102 | 2,115 | -69 | -3.2% | 164,400 |
2024/08/01 | 2,180 | 2,220 | 2,166 | 2,184 | -9 | -0.4% | 98,300 |
2024/07/31 | 2,165 | 2,193 | 2,152 | 2,193 | +30 | +1.4% | 44,500 |
2024/07/30 | 2,157 | 2,170 | 2,154 | 2,163 | -8 | -0.4% | 41,000 |
2024/07/29 | 2,160 | 2,177 | 2,160 | 2,171 | +16 | +0.7% | 33,300 |
2024/07/26 | 2,160 | 2,171 | 2,147 | 2,155 | +5 | +0.2% | 55,100 |
2024/07/25 | 2,158 | 2,167 | 2,135 | 2,150 | +9 | +0.4% | 67,100 |
2024/07/24 | 2,152 | 2,164 | 2,135 | 2,141 | -20 | -0.9% | 24,300 |
2024/07/23 | 2,143 | 2,164 | 2,143 | 2,161 | +18 | +0.8% | 29,400 |
2024/07/22 | 2,160 | 2,160 | 2,130 | 2,143 | -9 | -0.4% | 29,600 |
2024/07/19 | 2,139 | 2,156 | 2,128 | 2,152 | +13 | +0.6% | 42,300 |
2024/07/18 | 2,120 | 2,161 | 2,115 | 2,139 | +16 | +0.8% | 51,100 |
2024/07/17 | 2,140 | 2,147 | 2,114 | 2,123 | -7 | -0.3% | 32,500 |
2024/07/16 | 2,152 | 2,160 | 2,126 | 2,130 | -20 | -0.9% | 32,000 |
2024/07/12 | 2,143 | 2,160 | 2,140 | 2,150 | +5 | +0.2% | 57,100 |
2024/07/11 | 2,146 | 2,156 | 2,121 | 2,145 | +56 | +2.7% | 72,200 |
2024/07/10 | 2,100 | 2,100 | 2,069 | 2,089 | +7 | +0.3% | 45,400 |
2024/07/09 | 2,051 | 2,091 | 2,051 | 2,082 | +16 | +0.8% | 37,800 |
2024/07/08 | 2,076 | 2,093 | 2,065 | 2,066 | -9 | -0.4% | 37,600 |
2024/07/05 | 2,118 | 2,125 | 2,074 | 2,075 | -43 | -2% | 33,700 |
2024/07/04 | 2,115 | 2,120 | 2,111 | 2,118 | -1 | ±0% | 17,700 |
2024/07/03 | 2,117 | 2,125 | 2,112 | 2,119 | +2 | +0.1% | 22,500 |
2024/07/02 | 2,096 | 2,143 | 2,092 | 2,117 | +25 | +1.2% | 75,300 |
2024/07/01 | 2,113 | 2,118 | 2,082 | 2,092 | -21 | -1% | 43,400 |
2024/06/28 | 2,117 | 2,117 | 2,100 | 2,113 | +3 | +0.1% | 43,500 |
2024/06/27 | 2,100 | 2,120 | 2,100 | 2,110 | +10 | +0.5% | 35,700 |
2024/06/26 | 2,079 | 2,103 | 2,049 | 2,100 | +21 | +1% | 63,500 |
2024/06/25 | 2,100 | 2,103 | 2,069 | 2,079 | -11 | -0.5% | 79,600 |
2024/06/24 | 2,076 | 2,100 | 2,076 | 2,090 | +32 | +1.6% | 48,100 |
2024/06/21 | 2,086 | 2,097 | 2,051 | 2,058 | -28 | -1.3% | 95,400 |
2024/06/20 | 2,088 | 2,098 | 2,069 | 2,086 | +6 | +0.3% | 48,700 |
2024/06/19 | 2,059 | 2,091 | 2,059 | 2,080 | +14 | +0.7% | 42,500 |
2024/06/18 | 2,080 | 2,088 | 2,057 | 2,066 | +8 | +0.4% | 42,200 |
2024/06/17 | 2,066 | 2,067 | 2,023 | 2,058 | -20 | -1% | 36,200 |
2024/06/14 | 2,053 | 2,081 | 2,036 | 2,078 | +57 | +2.8% | 99,100 |
2024/06/13 | 2,030 | 2,030 | 2,010 | 2,021 | -4 | -0.2% | 33,100 |
2024/06/12 | 2,024 | 2,035 | 2,011 | 2,025 | -4 | -0.2% | 26,500 |
2024/06/11 | 2,042 | 2,053 | 2,029 | 2,029 | -17 | -0.8% | 41,400 |
2024/06/10 | 2,042 | 2,050 | 2,038 | 2,046 | +4 | +0.2% | 28,400 |
2024/06/07 | 2,038 | 2,044 | 2,024 | 2,042 | +4 | +0.2% | 60,600 |
201~
250
件表示中 / 3721件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 202,100円 | +3.1% | -6.5% | 2.38% | 9.38倍 | 0.99倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
東和薬品 | 299,200円 | +7.9% | -3.3% | 2.67% | 8.32倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 295,700円 | +5.1% | -7.0% | 2.71% | 19.41倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ハートシード | 431,500円 | +174.2% | - | 0.00% | - | 12.95倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
杏林製薬 | 148,400円 | -2.4% | -52.3% | 3.84% | 17.76倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム